BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7031669)

  • 21. H-2 class I antigen expression on mouse teratocarcinoma cell lines.
    Démant P; Oudshoorn-Snoek M
    Immunogenetics; 1985; 22(6):543-52. PubMed ID: 4077148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teratocarcinoma antigen is secreted by epididymal cells and coupled to maturing sperm.
    Fox N; Damjanov I; Knowles BB; Solter D
    Exp Cell Res; 1982 Feb; 137(2):485-8. PubMed ID: 7035205
    [No Abstract]   [Full Text] [Related]  

  • 23. Detection of the circulating antibodies to teratocarcinomadefined antigens in patients with testicular tumours.
    Teodorczyk-Injeyan J; Jewett MA; Burke CA; Ostrand-Rosenberg S
    Clin Exp Immunol; 1980 Jun; 40(3):438-44. PubMed ID: 6998614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.
    Boon T; Van Pel A
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1519-23. PubMed ID: 274738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent regulation of H-2K and H-2D gene expression in murine teratocarcinoma somatic cell hybrids.
    Gmür R; Solter D; Knowles BB
    J Exp Med; 1980 Jun; 151(6):1349-59. PubMed ID: 7381363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages.
    Glaser RM; Marshak-Rothstein A
    Eur J Immunol; 1990 Sep; 20(9):1917-25. PubMed ID: 2209698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation.
    Bosco N; Swee LK; Bénard A; Ceredig R; Rolink A
    Exp Hematol; 2010 Mar; 38(3):222-232.e2. PubMed ID: 20045443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semisyngeneic hybrid resistance to murine teratocarcinoma cells.
    Bishop GA; Dove WF
    Immunogenetics; 1980; 10(4):383-93. PubMed ID: 22457930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells.
    Nunn ME; Herberman RB; Holden HT
    Int J Cancer; 1977 Sep; 20(3):381-7. PubMed ID: 903189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of demonstrable H-2 antigens on the surface of teratocarcinoma 402AX of the mouse maintained in vivo.
    Isa AM
    Transplantation; 1976 Mar; 21(3):196-8. PubMed ID: 781924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cells.
    Croce CM; Linnenbach A; Huebner K; Parnes JR; Margulies DH; Appella E; Seidman JG
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5754-8. PubMed ID: 6170985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mouse teratocarcinoma: studies of antigens at the surface of multipotential cells (author's transl)].
    Dexter DL; Buc-Caron MH; Jakob H; Nicolas JF; Gachelin G
    Ann Microbiol (Paris); 1974; 125B(3):347-56. PubMed ID: 4142840
    [No Abstract]   [Full Text] [Related]  

  • 35. Thymic MHC class I gene regulation of susceptibility to lymphocytic choriomeningitis.
    Speiser DE; Zinkernagel RM
    Thymus; 1990; 16(3-4):187-93. PubMed ID: 2293422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Murine teratocarcinoma: origin and relation to early embryonic cells].
    Condamine H
    Reprod Nutr Dev (1980); 1980; 20(2):499-522. PubMed ID: 6296937
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental teratocarcinoma in mice: a model system for the study of the relationship between cellular surface antigens and embryonic differentiation].
    Gachelin G
    Bull Cancer; 1976; 63(1):95-110. PubMed ID: 62594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential H-2 antigen expression in teratocarcinoma-fibroblast hybrids.
    Sionov RV; Gallily R
    Exp Clin Immunogenet; 1995; 12(4):238-44. PubMed ID: 8919356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.
    Nakamura E; Kubota H; Sato M; Sugie T; Yoshida O; Minato N
    J Immunol; 1997 Jun; 158(11):5338-48. PubMed ID: 9164954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.